California will begin selling long-acting, low-cost insulin in January, becoming the first state to bypass major pharmaceutical companies, Gov. Gavin Newsom (D-CA) announced Thursday. The move marks a key victory in Newsom’s effort to lower healthcare costs through state-branded medications.

Newsom’s announcement comes shortly after President Donald Trump unveiled TrumpRX, a government website that would let people pay cash for certain prescription drugs at prices negotiated by the federal government. It remains unclear how the program would affect Americans covered by private insurance, Medicare, or Medicaid.

Recommended Stories

Republican senators demand answers from Trump FDA on abortion pill approval

What to know about Chikungunya virus after case in New York

Illinois spent

See Full Page